Results 91 to 100 of about 937 (188)

Reply to: “Questioning Conclusions and Statements on the German HTA System: A Critical Perspective”

open access: yes
Clinical Pharmacology &Therapeutics, Volume 117, Issue 1, Page 24-24, January 2025.
James Harnett   +3 more
wiley   +1 more source

Infantile Hypophosphatasia: Clinical Case

open access: yesВопросы современной педиатрии, 2020
Background. Hypophosphatasia is rare hereditary disease caused by deficiency of the tissue-nonspecific alkaline phosphatase isozyme. It manifests with bone and teeth mineralisation defects, electrolyte imbalance, respiratory disorders, convulsive ...
Tatyana V. Gabrusskaya   +3 more
doaj   +1 more source

Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry

open access: yesBMC Musculoskeletal Disorders, 2019
Background Hypophosphatasia (HPP) is a rare, systemic disease caused by mutation(s) within the ALPL gene encoding tissue-nonspecific alkaline phosphatase (ALP).
Wolfgang Högler   +9 more
doaj   +1 more source

ENPP1 Inhibition: A Promising Oral Therapy for Later-Onset Hypophosphatasia [PDF]

open access: yes
Hypophosphatasia (HPP) is a rare, inherited metabolic bone disorder characterized by deficient activity of tissue-nonspecific alkaline phosphatase (TNAP), an enzyme encoded by the ALPL gene.
MacRae, Vicky
core   +1 more source

Natural history of perinatal and infantile hypophosphatasia: A retrospective study [PDF]

open access: yes, 2019
Objective: To report clinical characteristics and medical history data obtained retrospectively for a large cohort of pediatric patients with perinatal and infantile hypophosphatasia.
Argente, Jesús   +17 more
core   +1 more source

HYPOPHOSPHATASIA IN ADULTS: CLINICAL CASES AND LITERATURE REVIEW

open access: yesОстеопороз и остеопатии, 2015
Hypophosphatasia is a rare inborn error of metabolism caused by mutations in the gene encoding tissue-nonspecific isoenzyme of alkaline phosphatase. Inexpressive clinical picture of the disease in adults is often difficult to diagnose.
S S Rodionova   +4 more
doaj   +1 more source

Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. [PDF]

open access: yes, 2019
BACKGROUND: Our previous phase 2, open-label study of 11 infants and young children with life-threatening perinatal or infantile hypophosphatasia showed 1 year safety and efficacy of asfotase alfa, an enzyme replacement therapy.
Balasubramaniam   +29 more
core   +1 more source

Clinical and genetic aspects of mild hypophosphatasia in Japanese patients [PDF]

open access: yes, 2019
Background: Hypophosphatasia (HPP) is a rare inborn error of metabolism that results from a dysfunctional tissue non-specific alkaline phosphatase enzyme (TNSALP).
Akiyama, Tomoyuki   +8 more
core   +1 more source

Hypophosphatasia : diagnosis and clinical signs - a dental surgeon perspective [PDF]

open access: yes, 2016
Hypophosphatasia (HPP) is a rare inherited metabolic disease in which mutations in the ALPL gene (encoding tissue-nonspecific alkaline phosphatase) result in varying degrees of enzyme deficiency.
Bloch-Zupan, A. (Agnès)
core   +2 more sources

A homozygous missense variant in the alkaline phosphatase gene ALPL is associated with a severe form of canine hypophosphatasia [PDF]

open access: yes, 2019
Inherited skeletal disorders affect both humans and animals. In the current study, we have performed series of clinical, pathological and genetic examinations to characterize a previously unreported skeletal disease in the Karelian Bear Dog (KBD) breed ...
Arumilli, Meharji   +8 more
core   +2 more sources

Home - About - Disclaimer - Privacy